Search

Your search keyword '"Zhang, Meini"' showing total 13 results
Start Over Author "Zhang, Meini" Search Limiters Full Text
13 results on '"Zhang, Meini"'

2. A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis

Author

Yin, Jian, primary, Zhao, Mingming, additional, Xu, Xianhao, additional, Zhang, Meini, additional, Xu, Zucai, additional, Li, Zunbo, additional, Qin, Xinyue, additional, Li, Zhuyi, additional, Zhao, Chongbo, additional, Zhou, Hongyu, additional, Ma, Ying, additional, Cao, Wenfeng, additional, Wang, Guoping, additional, Lin, Yongzhong, additional, Zhang, Jizhong, additional, Zhang, Xu, additional, Cai, Hongbin, additional, Qian, Weidong, additional, Wang, Yiqi, additional, Zhang, Xinghu, additional, Liu, Guangzhi, additional, Wang, Jiawei, additional, Qiu, Wei, additional, Min, Lianqiu, additional, Li, Jing, additional, Deng, Hui, additional, Chu, Lan, additional, Zhang, Yifan, additional, and Fang, Jianmin, additional

Published
2024
Full Text
View/download PDF

3. Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study

Author

Quan, Chao, primary, Zhou, Hongyu, additional, Yang, Huan, additional, Jiao, Zheng, additional, Zhang, Meini, additional, Zhang, Baorong, additional, Tan, Guojun, additional, Bu, Bitao, additional, Jin, Tao, additional, Li, Chunyang, additional, Xue, Qun, additional, Dong, Huiqing, additional, Shi, Fudong, additional, Qin, Xinyue, additional, Zhang, Xinghu, additional, Gao, Feng, additional, Zhang, Hua, additional, Wang, Jiawei, additional, Hu, Xueqiang, additional, Chen, Yueting, additional, Liu, Jue, additional, and Qiu, Wei, additional

Published
2024
Full Text
View/download PDF

7. A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China

Author

Tan, Guojun, Xu, Yan, Wang, Weizhi, Wang, Lihua, Li, Chunyang, Zhang, Xinghu, Zhou, Hongyu, Dong, Huiqing, Zhang, Meini, Jin, Tao, Yang, Huan, Cui, Liying, and Guo, Li

Subjects
China, Inpatients, Cross-Sectional Studies, Multiple Sclerosis, Cost of Illness, Neurology, Humans, Neurology (clinical), General Medicine, Middle Aged, Retrospective Studies
Abstract

To assess the disease burden and health economics of inpatients with multiple sclerosis (MS) in China by evaluating the direct, indirect, and intangible costs.A total of 863 patients were included for a cross-sectional retrospective study in 50 centers. The direct economic burden was measured by the cost of hospitalization and out-of-hospital application drugs, and the indirect economic burden was measured by the human capital method. The disability-adjusted life year (DALY) was used to express the intangible economic burden. Cost-utility analysis (CUA) using DALYs as indicators of health benefits was performed by calculating the incremental cost-utility ratio.The mean direct economic burden/year, daily medication expenses/year, DALY, indirect economic burden, and indirect economic burden/year were 27,655.57 Yuan, 17,944.97 Yuan, 10.89 Yuan, 512,041.7 Yuan, and 11,299.85 Yuan, respectively. For the study period of two years, the direct economic burden, daily medication expense, and indirect economic burden were 48.6%, 31.5%, and 19.85% of the total economic burden, respectively. Disease burden and the number of episodes of remission were not statistically significant (p0.001). The direct economic burden and total economic burden of the disease-modifying therapy (DMT) group were higher than those of the non-DMT group, but DALYs had no statistical significance (p0.001). CUA showed that inpatients with MS in the DMT group received a DALY every time compared with the non-DMT group.The DALY losses are concentrated in young and middle-aged Chinese people. In this two-year study, CUA prompted the application of DMT drugs to increase the economic burden and DALYs. However, follow-up time is still short, and further follow-up observation is required.

Published
2022
Full Text
View/download PDF

8. Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of Multiple Sclerosis Patient Survival Report 2018

Author

Zhou, Ran, primary, Zeng, Qiuming, additional, Yang, Huan, additional, Xu, Yan, additional, Tan, Guojun, additional, Liu, Hongbo, additional, Wang, Lihua, additional, Zhou, Hongyu, additional, Zhang, Meini, additional, Feng, Jinzhou, additional, Jin, Tao, additional, Zhang, Xinghu, additional, Wang, Jiawei, additional, Zhang, Xu, additional, Gao, Feng, additional, Yang, Chunsheng, additional, Bu, Bitao, additional, Li, Chunyang, additional, Zhang, Min, additional, Dong, Huiqing, additional, Lin, Aiyu, additional, Liu, Weibin, additional, Wu, Lei, additional, Wang, Manxia, additional, Tang, Yulan, additional, Wang, Honghao, additional, Long, Youming, additional, Wang, Zhe, additional, and Zheng, Weihong, additional

Published
2021
Full Text
View/download PDF

11. Athenoxat-1, Night Vision Experiments in LEO

Author

Manzoni, Giulio, Brama, Yesie L., and Zhang, Meini

Abstract

On 16th December 2015 Athenoxat-1 was launched by a PSLV from India in to Equatorial Orbit. Athenoxat-1 has been developed by Microspace Rapid Pte Ltd to demonstrate the feasibility of night vision imaging on a 3U Cubesat. The night vision payload is based on a high sensitive CCD and, in combination with the large optical aperture allows for very fast imaging of Earth surface in the night with 25m resolution. In addition to the main payload, Athenoxat-1 is equipped with 4 optical payloads for wide angle and horizon imaging. Sensor placement allows capturing a synchronized view of Earth and Space across almost 4Pi steradians thereby allowing various ADCS experiments such as Nadir determination and Moon tracking. Attitude control is achieved by magnetorquers and reaction wheels specifically developed for this mission. The talk will focus on the mission achievements, difficulties and challenges and, while discussing the lessons learned, will trace a roadmap for future work.

Published
2016

13. High-Temperature Dielectric Relaxation in Pb( Mg1/3 Nb2/3) O3- PbTiO3 Single Crystals.

Author

Wang, Chunchang, Zhang, Meini, Xia, Wei, and Tan, X.

Subjects
*OXYGEN, *ELECTRODES, *DIELECTRIC properties, *CRYSTALS, *FERROELECTRIC crystals
Abstract

We reported the dielectric properties of Pb( Mg1/3 Nb2/3) O3- PbTiO3 single crystal in the temperature range of 300-1073 K and the frequency range of 100 Hz-10 MHz. Our results showed the coexistence of both true- and pseudo-relaxor behaviors in the crystal. The true relaxor behavior related to the paraelectric-ferroelectric phase transition occurs at~423 K. The pseudo-relaxor behavior appearing at~773 K was found to be related to oxygen vacancies. Further investigation reveals that the pseudo-relaxor behavior has fine structure: it contains two oxygen-vacancy-related relaxation processes. The low-temperature relaxation process is a dipolar relaxation created by the hopping motions of the oxygen vacancies, and the high-temperature relaxation process is a Maxwell-Wagner relaxation caused by the sample/electrode contacts. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results